Perfusion Technology

Cytomedix Acquires Aldagen

9 Feb 2012

Conference Call Begins at 10:00 A.M. Eastern Time February 9GAITHERSBURG, MD -- Cytomedix, Inc. (OT...

Cytomedix Expands Commitment to Regenerative Medicine With Acquisition of Aldagen

8 Feb 2012

GAITHERSBURG, MD-- - Cytomedix, Inc. , a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announces the completion of the acquisition of Aldagen, ...

Positron Completes Agreement With Institute of Nuclear Research, Troitsk, Russia for Additional Strontium-82 Supply

7 Feb 2012

FISHERS, Ind., Feb. 7, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC.OB - News), through its wholly owned subsidiary, Manhattan Isotope Technology, LLC (MIT), is pleased to announce the execution of a Memorandum ...